Drug intelligence / Profile preview

XJB-5-131

Development stage
Preclinical
Lead developer
Solano Pharmaceuticals
Modality
Small Molecules, Peptides
Administration
Intraarticular, Intraperitoneal, Intravenous, Intravesical, Ophthalmic
01

Overview

XJB-5-131 is a synthetic, mitochondria-targeted nitroxide antioxidant and electron scavenger. It is a bi-functional conjugate consisting of a mitochondrial targeting peptide isostere derived from the Leu-D-Phe-Pro-Val-Orn segment of the antibiotic gramicidin S, linked to the stable nitroxide radical TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl). XJB-5-131 acts as a superoxide dismutase (SOD) mimic and a mild uncoupler of oxidative phosphorylation, neutralizing reactive oxygen species (ROS) directly within the mitochondria and preventing lipid peroxidation of cardiolipin and phosphatidylserine. It has been investigated preclinically for various conditions associated with oxidative stress and mitochondrial dysfunction, including Huntington's disease, traumatic brain injury, spinal cord injury, hemorrhagic shock, osteoarthritis, and radiation-induced cystitis.

Other names
XJB 5 131XJB5 131XJB-5 131

Beyond the preview

Go deeper on XJB-5-131.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on XJB-5-131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call